|
2026 Journal Article World Health Organization classification of tumours of the breast 6th edition 2026Quinn, Cecily, Tan, Puay Hoon, Allison, Kimberly H, Brogi, Edi, Lakhani, Sunil R, Schnitt, Stuart J, Fox, Stephen B, Jaffer, Shabnam, Sahin, Aysegul, Salgado, Roberto, Sapino, Anna, Adjei, Ernest Kwasi, Geiersbach, Katherine, Helbich, Thomas H, Lambertini, Matteo, Sotiriou, Christos, Hodge, Jennelle C, Khoury, Joseph D, Rekhi, Bharat, Ryska, Ales, Tse, Gary, Field, Andrew, Wijesinghe, Harshima, Puspanathan, Pavitratha, Giesen, Christine, Ruiz, Blanca Iciar Indave, Ellis, Ian, Lokuhetty, Dilani and WCT Standing Editorial Board (2026). World Health Organization classification of tumours of the breast 6th edition 2026. Histopathology his.70149. doi: 10.1111/his.70149 |
|
2026 Journal Article Integrating breast tumour homologous recombination deficiency status to aid germline<i> BRCA1</i> and<i> BRCA2</i> variant classificationFortuno, Cristina, Zhang, Jia, Koufariotis, Lambros T., Hollway, Georgina, Wood, Scott, V. Pearson, John, Simpson, Peter T., Lakhani, Sunil R., Reed, Amy E. Mccart, Thorne, Heather, Mann, G. Bruce, Skandarajah, Anita R., Devereux, Lisa, Zhao, Qihong, Silva, Dilanka L. De, Lindeman, Geoffrey J., Waring, Paul, James, Paul A., Campbell, Ian, Spurdle, Amanda B. and Waddell, Nicola (2026). Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification. Ebiomedicine, 126 106199, 106199. doi: 10.1016/j.ebiom.2026.106199 |
|
2026 Conference Publication Improving Diagnostic Reproducibility of Invasive Lobular Carcinoma: A Proposal for a New Architecture-Based ClassificationDjerroudi, Lounes, De Schepper, Maxim, Lakhani, Sunil, Pareja, Fresia, Derksen, Patrick, Brogi, Edi, Schnitt, Stuart, Floris, Giuseppe and Vincent-Salomon, Anne (2026). Improving Diagnostic Reproducibility of Invasive Lobular Carcinoma: A Proposal for a New Architecture-Based Classification. 115th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), San Antonio Tx, Mar 21-26, 2026. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.labinv.2025.104403 |
|
2026 Journal Article Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunitiesNones, Katia, Lakis, Vanessa, Dalley, Andrew J., Ryan, Kimberley, Chittoory, Haarika, Ferguson, Kaltin, Fitzgerald, Kate, Newell, Felicity, Koufariotis, Lambros T., Bashirzadeh, Farzad, Son, Jung Hwa, Singh, Mahendra, Nandakumar, Lakshmy, Fairbairn, David, Cummings, Margaret, Steinfort, Daniel, Christie, Jemma J., Gibney, Matthew, Williamson, Jonathan P., Pattison, Andrew, McIntosh, Louise, Pahoff, Carl, Nguyen, Phan Tien, Solujic, Jelena, Brown, Michael, Twaddell, Scott, Arnold, David, Grainge, Christopher, Gune, Shailendra ... Fielding, David (2026). Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities. Genome Medicine, 18 (1) 47. doi: 10.1186/s13073-026-01624-y |
|
2026 Journal Article Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapyWong, Joshua K. M., Lam, Pui Yeng, Coleborn, Elaina, Alim, Louisa, Jose, Jiya, Tu, Cui, Antczak, Magdalena, Dietmair, Bettina, Hagh, Arghavan Golbaz, Noronha, Lucia, Cheetham, Seth W., Hooper, John, Beavis, Paul A., Merino, Delphine, Berthelet, Jean, Aoude, Lauren G., McCart-Reed, Amy E., Lakhani, Sunil, Simpson, Peter T., Rossi, Gustavo R., Brooks, Andrew J., Jones, Martina L., Simpson, Fiona and Souza-Fonseca-Guimaraes, Fernando (2026). Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy. Molecular Therapy, 34 (3), 1382-1398. doi: 10.1016/j.ymthe.2025.11.021 |
|
2026 Journal Article Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in AustraliaRedfern, Andrew, Lim, Elgene, Lakhani, Sunil, Pathmanathan, Nirmala, Selva-Nayagam, Sudarsha, McCarthy, Nicole, Yeo, Belinda, Dessauvagie, Benjamin and Farshid, Gelareh (2026). Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia. Asia-Pacific Journal of Clinical Oncology, 22 (3) ajco.70069, 381-391. doi: 10.1111/ajco.70069 |
|
2026 Book Chapter The breastSokolova, Anna, Simpson, Peter T. and Lakhani, Sunil R. (2026). The breast. Robbins, Cotran & Kumar pathologic basis of disease. (pp. 944-969) edited by Jon C. Aster, Abul K. Abbas, Vinay Kumar, Jayanta Debnath and Abhijit Das. Philadelphia, PA United States: Elsevier. |
|
2025 Journal Article Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progressionKader, Tanjina, Zethoven, Maia, Mahale, Sakshi, Saunders, Hugo, Tjoeka, Lauren, Lehmann, Rebecca, Jayawardana, Madawa W., Pang, Jia-min, Lesche, Dorothea, Rajan, Neeha, Semple, Timothy, Lee, Jue Er Amanda, Lupat, Richard, Byrne, David J., Hughes, Siobhan, Nguyen, Hoa, Lai, Siqi, Pechlivanis, Maree, Craig, Olivia, Devereux, Lisa, House, Eloise, Jayasinghe, Sureshni, Kaufmann, Tom L., Schwarz, Roland F., Green, Andrew R., Miligy, Islam M., Cummings, Margaret, Lakhani, Sunil, Campbell, Ian G. ... Gorringe, Kylie L. (2025). Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression. Journal of Pathology, 268 (1) path.6461, 1-12. doi: 10.1002/path.6461 |
|
2025 Journal Article Integrated profiling of metaplastic breast cancer identifies putative master regulators of intratumoral heterogeneityFeng, Yufan, Xiong, Albert, Mulay, Onkar, Sokolova, Anna, Lim, Malcolm, Van Haeringen, Benjamin, McGuire, Natasha, de Luca, Xavier, Simpson, Peter T., Nguyen, Quan, Lakhani, Sunil R. and McCart Reed, Amy E. (2025). Integrated profiling of metaplastic breast cancer identifies putative master regulators of intratumoral heterogeneity. npj Breast Cancer, 11 (1) 89. doi: 10.1038/s41523-025-00807-x |
|
2025 Conference Publication Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breastWong, Clarissa Jing Wen, Nasir, Nur Diyana Md, Koh, Valerie Cui Yun, Campbell, Fiona, Fox, Stephen, Lakhani, Sunil R., Myles, Nickolas, Yip, George, Colling, Richard, Cree, Ian A., Lokuhetty, Dilani and Tan, Puay Hoon (2025). Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.FCS2024-P78 |
|
2025 Journal Article Genomic predictive biomarkers in breast cancer: the haves and have notsBeecher, Kate, Kulasegaran, Tivya, Lakhani, Sunil R. and McCart Reed, Amy E. (2025). Genomic predictive biomarkers in breast cancer: the haves and have nots. International Journal of Molecular Sciences, 26 (15) 7300, 7300-15. doi: 10.3390/ijms26157300 |
|
2025 Conference Publication Multi-omic explainable machine learning improves cancer treatment outcome predictionTran, Khoa A., Addala, Venkateswar, Koufariotis, Lambros T., Zhang, Jia, Wood, Scott, Leonard, Conrad, Hoeijmakers, Lotte L., Blank, Christian U., Crispin-Ortuzar, Mireia, McCart. Reed, Amy, Inglis, Po-ling, Lakhani, Sunil R., Williams, Elizabeth D., Pearson, John V., Kondrashova, Olga and Waddell, Nicola (2025). Multi-omic explainable machine learning improves cancer treatment outcome prediction. AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning, Montreal, QC Canada, 10-12 July 2025. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1557-3265.aimachine-a051 |
|
2025 Journal Article Pitfalls in the histological diagnosis of morphologic variants of invasive lobular carcinoma of the breastFloris, Giuseppe, Djerroudi, Lounes, Zels, Gitte, De Schepper, Maxim, Richard, François, Brahimaj, Rigleta, Derksen, Patrick W.B., Christgen, Matthias, Lakhani, Sunil R., Van Diest, Paul J., Brogi, Edi, Desmedt, Christine, Schnitt, Stuart J. and Vincent-Salomon, Anne (2025). Pitfalls in the histological diagnosis of morphologic variants of invasive lobular carcinoma of the breast. Modern Pathology, 38 (9) 100837. doi: 10.1016/j.modpat.2025.100837 |
|
2025 Conference Publication OlympiA: A phase 3, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients w/ germline BRCA1 & BRCA2 pathogenic variants & highrisk HER2-negative primary breast cancerGarber, Judy, Cameron, David, Campbell, Christine, Yothers, Greg, Taboada, Maria, El-Abed, Sarra, Rastogi, Priya, Paterson, Vicki, Kang, Jinyu, Zafonte, Stephanie, Liu, Xiaochun, Viale, Giuseppe, Spanic, Tanja, Schmutzler, Rita, Piccart, Martine, Loibl, Sibylle, Linderholm, Barbro, Lakhani, Sunil R., Korde, Larissa, Gnant, Michael, Gelmon, Karen, Friedman, Sue, Freeman, Tanner, Domchek, Susan M., Aktan, Gursel, Gelber, Richard D., Geyer, Charles E. and Tutt, Andrew N. J. (2025). OlympiA: A phase 3, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients w/ germline BRCA1 & BRCA2 pathogenic variants & highrisk HER2-negative primary breast cancer. San Antonio Breast Cancer Symposium, San Antonio Tx, Dec 10-13, 2024. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1557-3265.SABCS24-GS1-09 |
|
2025 Conference Publication Early detection of ovarian cancer: An accurate high-throughput extracellular vesicle testSalomon, Carlos, Lai, Andrew, Guanzon, Dominic, Sharma, Shayna, Scholz-Romero, Katherin, Razo, Melissa, Barnard, Amanda, Choolani, Mahesh, Palma, Carlos, Khanabdali, Ramin, Lakhani, Sunil R., Coward, Jermaine, Hinch, Leearne, Ferguson, Kaltin, Perrin, Lewis, Lourie, Rohan, DeFazio, Anna, Hooper, John D. and Rice, Gregory Edward (2025). Early detection of ovarian cancer: An accurate high-throughput extracellular vesicle test. 2025 ASCO Annual Meeting, Chicago, IL United States, 30 May - 3 June 2025. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2025.43.16_suppl.5582 |
|
2025 Journal Article ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selectionSokolova, Anna, Joshi, Vaibhavi, Chittoory, Haarika, Walsh, Michael, Lim, Malcolm, Kutasovic, Jamie R., Ferguson, Kaltin, Simpson, Peter T., Lakhani, Sunil R. and Reed, Amy E. McCart (2025). ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selection. Histopathology, 87 (2), 223-234. doi: 10.1111/his.15465 |
|
2025 Journal Article Classification of fibroepithelial lesions of the breast in core needle biopsy with implications for further managementRakha, Emad A., Quinn, Cecily, Raymond, Wendy, Allison, Kimberly H., Badve, Sunil S., Brogi, Edi, Callagy, Grace, Charafe-Jauffret, Emmanuelle, Chen, Chih Jung, Chen, Yunn-Yi, Collins, Laura C., Cserni, Gábor, Djerroudi, Lounes, Jaffer, Shabnam, Foschini, Maria Pia, Gobbi, Helenice, Gudi, Mihir, Harada, Oi, Kulka, Janina, Kuroda, Hajime, Lakhani, Sunil R., Li, Xiaoxian, Moriya, Takuya, O'Toole, Sandra A., Pinder, Sarah E., Provenzano, Elena, Sahin, Aysegul A., Schmitt, Fernando, Shaaban, Abeer M. ... Tan, Puay Hoon (2025). Classification of fibroepithelial lesions of the breast in core needle biopsy with implications for further management. Modern Pathology, 38 (5) 100734, 1-21. doi: 10.1016/j.modpat.2025.100734 |
|
2025 Journal Article Malignant phyllodes tumours of the breast: the case for revising WHO’s ‘full house’ diagnostic criteriaTan, Puay Hoon, Ellis, Ian O, Allison, Kimberly H, Badve, Sunil S, Brogi, Edi, Callagy, Grace, Charafe‐Jauffret, Emmanuelle, Chen, Chih‐Jung, Chen, Yunn‐Yi, Collins, Laura C, Cserni, Gábor, Djerroudi, Lounes, Foschini, Maria Pia, Fox, Stephen B, Gobbi, Helenice, Gudi, Mihir, Harada, Oi, Jaffer, Shabnam, Kulka, Janina, Kuroda, Hajime, Lakhani, Sunil R, Li, Xiaoxian, Moriya, Takuya, O'Toole, Sandra, Pinder, Sarah E, Provenzano, Elena, Quinn, Cecily, Raymond, Wendy, Sahin, Aysegul A ... Rakha, Emad A (2025). Malignant phyllodes tumours of the breast: the case for revising WHO’s ‘full house’ diagnostic criteria. Histopathology, 87 (2), 169-182. doi: 10.1111/his.15455 |
|
2025 Journal Article A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancerMiranda, Mariska, Saunus, Jodi M., Akgül, Seçkin, Marjaneh, Mahdi Moradi, Kutasovic, Jamie R., Shi, Wei, Chatterjee, Oishee, Casciello, Francesco, Rozali, Esdy, Handoko, Herlina Y., Wiegmans, Adrian P., Liu, Tianqing, Lee, Jason S., Day, Bryan W., Edwards, Stacey L., French, Juliet D., McCart Reed, Amy E., Chenevix-Trench, Georgia, Khanna, Kum Kum, Simpson, Peter T., Lakhani, Sunil R. and Al-Ejeh, Fares (2025). A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer. Fortune Journal of Health Sciences, 250-266. doi: 10.26502/fjhs.271 |
|
2025 Journal Article Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assayNikseresht, S., Shewell, L. K., Day, C. J., Jennings, M. P., Chittoory, H., McCart Reed, A. E., Simpson, P. T., Lakhani, S. R., Nabiee, R., Moore, M., Khanabdali, R., Hinch, L. M. and Rice, G. E. (2025). Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay. Breast Cancer Research and Treatment, 211 (3) 188534, 1-11. doi: 10.1007/s10549-025-07672-z |
